|
|
|
|
|
| Manufacturer of VELscope Oral Cancer Detection System Poised for Continued Growth |
|
|
| The human papillomavirus is one of the most insidious and dangerous sexually transmitted diseases for women, as it has been linked to a vast majority of cervical cancers. We are now seeing the effects of HPV infection in men, and the marked increase in oral cancer - coupled with the well-known increased risk for penile and anal cancers - suggests that both sexes face equally serious health consequences from this virus. |
|
|
| NYC's Top Mover Helps Get the Message Out for Artist Stephanie Engstrom's Groundbreaking New Show |
|
|
| Folbot, the leading American folding kayak manufacturer, is thinking pink. To help raise money to aid in the fight against breast cancer, all Folbot models are now available in pink -- and 10% of the price of any pink kayak sold will be donated to a national breast cancer research organization. |
|
|
| Nanobiotix, an emerging nanomedicine company focused on cancer therapy, announced today that the Company and its partner, Malaysian Biotechnology Corporation Sdn Bhd (BiotechCorp), will initially focus their collaboration on developing point-of-care (P-O-C) diagnostics and drug delivery systems for tropical diseases, such as malaria. BiotechCorp has acquired an exclusive, global license to a Nanobiotix nanotechnology platform for non-cancer purposes. As part of the collaboration, three BiotechCorp scientists will take up residence at Nanobiotix for a period of 12 months to undergo the... |
|
|
| Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today it has received a contract for $933,000 from the Department of Defense (US Army) to continue research and development of DNA-based vaccines delivered via its proprietary electroporation system. The contract, titled “Design and Engineering of the Elgen Gene Delivery System for Screening and Validation of Vaccine Candidates of Military Relevance,” will run through May 2010. This project is focused on identifying DNA vaccine... |
|
|
| LegalView reported a new treatment for mesothelioma patients currently being studied in a clinical trial. The treatment includes the monitoring of mesothelioma cancer symptoms and quality of life with an electronic handheld tool. |
|
|
| TomoTherapy Incorporated (NASDAQ: TOMO) announced today that it is developing the world’s first mobile radiation therapy solution. The company plans to house its revolutionary Hi·Art® treatment system in trailers that would be available for use by TomoTherapy customers during new construction, in advance of system installation, to alleviate temporary backlogs, or as a permanent placement for centers that are unable to expand their facility. The announcement was made today at the 50th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO). |
|
|
| This year's 4th annual 'Pink Party®' charity event raised over one million dollars. The event's proceeds benefit Cedars-Sinai Medical Center Women's Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute, directed by Beth Y. Karlan, M.D. |
|
|
| Nanobiotix, an emerging nanomedicine company focused on cancer therapy, announced today that the European Patent Office (EPO) has issued Patent No. 1744789 to the Company, related to its “novel activable particles that can be used in the health sector.” |
|
|
